Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL) for children and adolescents (Q39667736)
Jump to navigation
Jump to search
scientific article published on September 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL) for children and adolescents |
scientific article published on September 1, 2003 |
Statements
1 reference
Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL) for children and adolescents (English)
1 reference
Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL®) for children and adolescents (Spanish)
K. J. Drachenberg
M. Heinzkill
E. Urban
1 September 2003
1 reference
1 reference
31
1 reference
5
1 reference
270-277
1 reference
Identifiers
1 reference
1 reference